Form 4: Alumis Inc. Executive Roy C. Hardiman Acquires Stock Options
SEC Form 4 Filing
Roy C. Hardiman, Chief Business & Strategy Officer of Alumis Inc., reports the acquisition of stock options.
Summary
- On February 18, 2025, Roy C. Hardiman, Chief Business & Strategy Officer of Alumis Inc., acquired stock options for 140,000 shares.
- The exercise price of these options is $5.06.
- 25% of the shares underlying the option vest on February 18, 2026, with the remaining shares vesting in equal monthly installments over the subsequent 36 months, contingent upon continuous service.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive. The granting of stock options is a standard practice and suggests confidence in the executive's future contributions. However, it's not a major event that would drastically alter the company's outlook.
Positives
- The acquisition of stock options by a key executive could signal confidence in the company's future performance.
Future Outlook
The vesting schedule indicates a long-term incentive plan for the executive, aligning their interests with the company's performance over the next several years.
Industry Context
Stock option grants are a common form of executive compensation in the biotechnology industry, used to attract and retain talent and align their interests with shareholder value.
Comparison to Industry Standards
- Stock option grants are a standard component of compensation packages for executives in publicly traded companies, particularly in the biotech sector.
- The vesting schedule of 25% after one year followed by monthly installments is a typical structure to incentivize long-term commitment.
- Comparable companies in the biotech industry, such as Amgen, Gilead Sciences, and Biogen, also utilize stock options as part of their executive compensation plans.
Stakeholder Impact
- Shareholders may view the stock option grant as a positive sign, aligning executive interests with long-term company performance.
- Employees may see this as a positive sign of company stability and growth potential.
Key Dates
| Date | Description |
|---|---|
| 02/18/2025 | Date of the transaction: Roy C. Hardiman acquired stock options. |
| 02/18/2026 | 25% of the shares underlying the option vest. |
| 02/17/2035 | Expiration date of the stock options. |
| 02/20/2025 | Date of signature on the Form 4 filing. |
Keywords
stock options, Form 4, insider trading, ALMS, Alumis Inc., executive compensation, Roy C. Hardiman
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.